We previously demonstrated how sharing of rare variants (RVs) in distant affected relatives can be used to 2 identify variants causing a complex and heterogeneous disease. This approach tested whether single RVs 3 were shared by all sequenced affected family members. However, as with other study designs, joint analysis 4 of several RVs (e.g. within genes) is sometimes required to obtain sufficient statistical power. Further, 5 phenocopies can lead to false negatives for some causal RVs if complete sharing among affecteds is required.
latter feature can be critically important, as was the case in detection of a nonsense mutation in CDH1 23 shared among three affected second cousins, but also present in the unaffected parents who transmitted 24 this variant [Bureau et al. 2014a , Figure 1 ]. We note GESE and RareIBD can be applied in "affected-only" 25 2 mode by setting the phenotype of unaffected subjects to unknown, even though not intended as such.
1 When reliable information about allele frequencies is available, some authors have argued for combining 2 a linkage signal with the association signal derived using known allele frequencies to increase statistical 3 power. Hu et al. [2014] proposed an extension of their previously developed Variant Annotation, Analysis 4 and Search Tool (VAAST), a likelihood-ratio-based RV association test that incorporates case/control 5 allele frequency differences and functional annotation into the likelihood. The aptly named pedigree-6 VAAST (pVAAST) employs a sequence-based model, where variants are tested for being directly causal 7 instead of merely linked to some unobserved disease variant (as in classical linkage analysis) in variant and 8 gene-based linkage analysis, and offers the option to combine this linkage information with the VAAST 9 statistic. GESE calculates a probability of segregation combining association and linkage signals requiring 10 knowledge (or an accurate estimate) of the variant frequency in the population. This feature of GESE 11 has the potential to increase power, but misspecification of variant frequencies, which is likely in family 12 samples with distinctly different or mixed genetic backgrounds, may yield spurious signals. Methods 13 relying on filtering of variants based on frequencies in external databases such as our RVS approach and 14 RareIBD are also susceptible to false positive signals from variants common in a study population but not 15 well represented in the utilized reference databases. However, the haplotype structure around a variant 16 contains information on the population frequency of variant that can be exploited to filter out common 17 variants without producing a frequency estimate as required by pVAAST and GESE. 18 GESE, pVAAST and RareIBD are designed for analysis of all RVs in a gene or genomic region, as is standard 19 when analyzing RVs to increase the proportion of subjects or families with at least one RV [Li and Leal 2008, 20 Lee et al. 2014]. Here we present an extension of our previously published single-variant RVS method for a 21 gene-based approach. Acknowledging phenocopies, diagnosis error and intra-familial genetic heterogeneity 22 exist in complex disorders, we further extend our method by relaxing the previous assumption that all 23 sequenced affected subjects must be carriers of the same causal variant, and by introducing an approach 24 based on haplotypes of known variants to detect which variants are not actually rare in the study population 25 3 despite being rare or completely absent in reference databases. Comparing our gene-based RV sharing 1 approach to alternative methods, we show in a simulation study that knowledge and use of allele frequencies 2 of rare variants in approaches such as GESE and the pVAAST linkage statistic does not lead to power 3 gains over methods such as RVS and RareIBD, which do not require knowledge of such frequencies and are 4 therefore more universally applicable. An implementation of our method RVS is available as open source 5 software from the Bioconductor project at bioconductor.org/packages/release/bioc/html/RVS.html. 6 Methods 7 Gene-based analysis: We initially presented the RVS approach for single variants [Bureau et al. 2014b ]. 8 As long as there is a single RV within a gene in the same family, the RVs are independent since the families 9 are unrelated, and the information can simply be pooled together and analyzed jointly. The abundance of 10 RVs in the human genome, however, implies that multiple RVs are likely to occur on the same haplotype 11 over a region such as a gene. Such RVs have identical sharing patterns, and are indistinguishable in 12 genetic analysis. Therefore, we redefine the units of analysis as the haplotypes of RVs over each genomic 13 region instead of individual RVs themselves. Simply taking the minimal RV sharing probability among 14 all RVs in the same gene in a family has the effect of merging RVs on the haplotype with the lowest 15 sharing probability. We detail in the section "Recoding rare variants haplotypes for rare variant sharing 16 computations" on page 7 a systematic approach to recode RVs into haplotypes based on genomic sequence.
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After this recoding, when two or more RVs (or haplotypes of several RVs) remain in the same gene in a 18 family, we retain one RV per family to compute the RV sharing probability. We propose using those RVs 19 with the sharing pattern yielding the lowest probability among all RVs present in the same gene. When we 20 do this, the test is no longer exact; the resulting p-value becomes an approximation of the exact p-value. 21 We examine the impact of this practice on Type I error in a simulation study, and in sequencing data from 22 individuals drawn from multiplex cleft families. 23 4 Partial sharing: We define the following random variables: 1 C i represents the number of copies of the RV observed in the sequence of subject i, 2 F j is the indicator variable that founder j introduced one copy of the RV into the pedigree, and 3 D ij is the number of generations (meioses) between subject i and his or her ancestor j.
4
For a set of n sequenced subjects for which the pedigree structure limits to one the number of copies of 5 the RV that they can share, we compute the probability that any subset of size k ≤ n shares a given RV.
6
Without loss of generality, we assume the n subjects are ordered such that subjects 1, . . . , k ≤ n share the 7 RV, and thus: 8 P ( the subset shares the RV )
The numerator is computed using the relationship 9 P (C 1 = · · · = C k = 1, C k+1 · · · = C n = 0)
where S h is the set of all subsets of size h among the n − k subjects not carrying the RV, and s 1 , . . . s h are 10 the indices of the subjects belonging to such a subset s ∈ S h . All terms on the right hand side are joint 11 sharing probabilities for a subset of k + h affected subjects, which can be computed using the approach 12 described in Section 2.1 of Bureau et al. [2014b] . Formulas for the denominator are also found there. To 13 simplify the notation, we define K = C 1 +· · ·+C n . For a single family, we define a RV sharing configuration 14 where k subjects share a RV as G k = (C 1 , . . . C n ) | K = k. The p-value of this configuration G k is the 15 sum of probabilities of all sharing configurations g with probability P g = P (g | K ≥ 1) lower or equal to 16 5 the probability of the observed configuration P G k = P (G k | K ≥ 1), and with size k (g) ≥ k, i.e.:
We note it is computationally advantageous to identify classes of all equiprobable configurations, to compute 2 their probability only once for a member of each class, and to multiply the probability by the number of 
In the current implementation, M is limited to 10 as the summation grows exponentially with M . This
13
M is the number of families with a RV, not the maximum size of the family sample, as only a fraction of 14 families harbor RVs in any given gene. This is not really a limitation -if the variant was seen in more 15 than ten families, it likely would not be rare.
16
Refining the definition of RVs:
The assumption that all copies of a RV seen in related members of a 17 pedigree are IBD is crucial to the validity of the RVS tests. Instead of relying solely on filtering of common 18 variants based on their frequencies in external reference databases, genome-wide genotype data enables 19 the identification of variants actually introduced multiple times to the family from unrelated founders and 20 most likely not rare in the population from which the family is drawn. Our approach is based on haplotypes 21 6 of known variants (common and rare). RVs seen on two or more haplotypes are discarded as introduced 1 multiple times into the family, e.g. being IBS without being IBD. We infer haplotypes by phasing the 2 sequence data in families prior to analysis. Given the need to include a sufficient number of common variants 3 within a genomic interval spanning a gene, and to ensure the quality of phasing, this approach is advisable 4 only with genomic sequence and not with capture-based exome sequencing data alone. and numbers of affected subjects for each possible sharing configuration of the sequenced affected members 23 from every family must be provided to the RVgene function to perform the test allowing for partial sharing.
24
Due to the computational demand of the convolution of the RV sharing event distribution for all families 25 7 involved, the number of families with RVs in the same gene is currently limited to 10, or fewer depending 1 of available RAM (the complete sharing test does not have this limitation). Another new feature of 2 the RVS package is its correction of sharing probabilities to account for cryptic relatedness using the 3 analytical approximation described in Bureau et al. [2014b] , based on a reimplementation of the RV 4 sharing probability computation using the gRain package for general computations on Bayesian networks.
5
The previous Monte Carlo approximation for cryptic relatedness correction has also been reimplemented.
6
Simulation study: We used 594 phased sequences from the CEU, TSI and GBR samples of the 1000 7 Genomes Project to define a population of haplotypes for each gene in the genome. Single nucleotide 8 variants (SNVs) seen more than once in this sample were used to define recoding haplotypes. RVs were 9 defined as SNVs with frequency < 1% among the 594 sequences (up to 5 copies). To evaluate haplotype 10 recoding in the context of a sequencing study with a family sample, we assumed a genetic origin to the 11 disease in all families and used the 47 simple pedigree structures (i.e., not allowing inbreeding or marriage 12 loops, removing 7 inbred pedigrees to limit computational complexity) from the second set of multiplex 13 cleft families (see section "Multiplex oral cleft families" on page 10). was assumed to be dominant with a penetrance in the range 0.5 -1.0 (the interval over which pVAAST 19 maximizes the LOD score). Since pVAAST requires specifying the amino acid substitution at the tested RV, 1 we assumed a substitution with a mild effect (alanine to valine). The severity of the mutation is actually 2 irrelevant for the linkage LOD score statistic, but is taken into account in the case-control composite 3 likelihood ratio test (CLRT) which is added to the linkage LOD score to obtain the CLRT for pedigrees 4 (CLRTp). Due to high computational demands of pVAAST, the number of Monte Carlo simulations to 5 estimate the p-value was set to 10,000. For RareIBD and GESE, the number of resampling simulations 6 was adaptively selected, increasing up to 10 7 for very small p-values. For GESE, we evaluated the Type data were generated for 153 affected relatives and 7 unaffected relatives (all unaffected individuals were from 20 Filipino families). We thus call this set the "WGS sample". In one Syrian pedigree, the 8 affected relatives 21 did not have any known common ancestor, so a sub-pedigree including 6 affected relatives descending from 22 a common couple of ancestors was used in the analysis, reducing the total number of affected subjects to 23 151 ( Table 2 ). The sequencing, alignment, and variant calling process was described in Holzinger et al.
24
[2017], who also reported on RVs observed in the WGS data from the Filipino and Syrian families.
25
In addition to a large proportion of families with four or more affected relatives, the WGS sample differs 1 from the WES sample by the presence of first degree relatives ( Supplementary Table 1 ). Thus, the distri-2 bution of the − log 10 probabilities of sharing a RV by all affected relatives within the respective families 3 (which is the potential − log 10 p-values when a RV is present in a single family) was more dispersed in the 4 WGS than the WES sample ( Supplementary Figure 4) . Recoding of rare variant haplotypes: It is possible for two or more RVs on distinct haplotypes to be on 6 the same inferred haplotype (due to failure of the inferred haplotypes to distinguish all actual haplotypes), 7 thus being incorrectly recoded together as one RV. To assess the frequency of such an event, we applied 8 our RV haplotype recoding procedure to intervals defined from 5 kb upstream to the transcription end of 9 each RefSeq gene (hg19 assembly) in a dataset simulated as described in the "Simulation study" section 10 above. There were 18,272 genes with at least one coding RV in the CEU, TSI and GBR samples. We 11 generated a total of 301,472 haplotypes with at least one coding RV (an average of 16.5 haplotypes per 12 gene, or 0.35 per gene per family). For 92.8% of these RV-bearing haplotypes, all coding RVs recoded to 13 that haplotype were on the same actual haplotype.
14 Type I error, power, and scalability: We computed the potential p-values as defined by Bureau et al.
15
[2014b] for every replicate at every penetrance level. These potential p-values were generally less than 16 10 −5 , and thus the simulated datasets were sufficiently informative to potentially reject the null hypothesis 17 at the adopted significance levels. In the simulation under the null hypothesis, computation of the partial 18 sharing gene-based test succeeded in 97% of 1000 replicates (those where RVs were seen in 10 or fewer 19 families), and computation of the complete sharing test always succeeded in this simulation. Type I error 20 was generally well controlled for RareIBD, the two versions of the RVS approach, and GESE when the 21 MAF was correctly estimated. A slight inflation at the most extreme p-values was observed however, 22 particularly for GESE ( Figure 1 ). Type I error inflation was severe for the pVAAST CLRTp test, and 23 12 somewhat substantial for GESE and pVAAST LOD when the MAF was underestimated by a factor of 10. 1Observed −log10(p−value)The performance of the gene-based tests at detecting causal RVs are compared for PEAR1 (Figure 2 , left) 2 and CDH13 (Figure 2, right) . Computation of the subset sharing gene-based test succeeded in 96% and 3 70% of replicates (where RVs were seen in 10 or fewer families) for PEAR1 and CDH13, respectively. Since 4 for pVAAST 10,000 simulations under the null did not allow us to estimate p-values below α = 1 × 10 −5 , except the LOD test of pVAAST. RareIBD had in most instances slightly higher power than its nearest 1 competitors. The test allowing for sharing by a subset of subjects had slightly greater power than the 2 complete sharing test for the small PEAR1 gene and slightly lower power than the complete sharing test 3 for the larger CDH13 gene. GESE had lower power than RareIBD and the RVS tests when applying 4 the stringent significance level suggested for GESE by Qiao et al. [2017] , for a fair comparison with tests 5 conditioning on the presence of at least one variant. Only when using the same α = 1 × 10 −5 significance 6 level as the other tests did GESE have slightly higher power in the small PEAR1 gene (Supplementary 7 Figure 1 ). The LOD test of pVAAST had low power, with the LOD score maximizing at 0 for all replicates 8 in the small PEAR1 gene and a majority of replicates in the larger CDH13 gene. When the relative 9 risk of causal RVs was equal to 10 and thus many unaffected carriers are expected, the linkage LOD test 10 of pVAAST had higher power that the other methods in the large CDH13 gene, but this power did not 11 14 increase further at higher relative risks. The CLRTp combining linkage and case-control association signals 1 gave the highest power under all alternative models for both genes, which is due to additional information 2 beyond variant segregation within families (examined here). Computing times for testing coding RVs in the 3 gene CDH13 in one replicate of the simulated dataset exhibited dramatic differences in scalability ( Table   4 3). We also examined the correlation of the − log 10 p-values of the five tests and found the partial and 5 complete sharing tests, GESE and RareIBD to be highly correlated, while these four tests are only weakly 6 correlated to the pVAAST LOD test ( Supplementary Figure 3, Figure 5 ).
9
Four of these eight families were Syrian, and the adjustment for unknown relationships performed as before 10 increased the p-value to 0.0015. Sharing by two or more subjects was observed in five families, but sharing 11 by all affected relatives occurred in only two families, so the complete sharing p-value was much higher. RVs on different haplotypes within the same family. This is a rare occurrence even in genes with multiple 21 RVs such as CDH13 used in our simulation, and taking the minimal sharing probability among them did 22 not lead to inflated Type I errors in our simulation study.
23
Phenocopies, diagnosis errors and intra-familial genetic heterogeneity clearly exist, so causal RVs may 1 not be shared by all affected relatives in any one pedigree. One way to detect excess sharing among 2 sequenced family members is then to examine partial sharing, i.e. sharing by a subset of affected subjects 3 in a family, and summing the probability of sharing patterns as or more extreme as the observed one within 4 and between families when computing the p-value. The test allowing partial sharing had a slight power 5 advantage over the complete sharing test for a gene with few RVs in our simulation based on the oral cleft 6 families, but a slight power disadvantage for a gene with many RVs, despite simulating data under genetic 7 models with phenocopies. This difference can be explained by an increased chance of partial sharing under 8 the null hypothesis when there are many RVs, while sharing by all affected subjects remains rare. The function of the number of families where the score is 2, which under the null hypothesis follows a binomial 23 distribution with success probability being the probability of sharing a RV by both affected relatives given 24 at least one is a carrier (e.g. 1/15 for affected first cousin pairs). In this setting both RVS tests simplify to 25 18 the exact tail probability of the same null binomial distribution (and while our method provides a closed-1 form solution, the gene-dropping simulation used in RareIBD is sampling from the binomial distribution to 2 compute the p-value). When all pedigrees have the same configuration of three or more affected subjects, 3 there will be slight differences between RareIBD and each of the RVS tests due to differences in the 4 ordering of the combinations of complete and partial sharing events across families, and hence of their null
